During the past decade, Marshall University Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshall University Medical Center" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshall University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "American College of Surgeons" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Marshall University Medical Center" are "Breast Cancer" (2 trials), "Migraine" (2 trials), "Breast Adenocarcinoma" (1 trials), "Chronic Migraine in Children" (1 trials) and "Colon Mucinous Adenocarcinoma" (1 trials). Many other conditions were trialed in "Marshall University Medical Center" in a lesser frequency.

Most popular intervention types in "Marshall University Medical Center" are "Drug" (10 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Laboratory Biomarker Analysis" (2 trials), "Lasmiditan" (2 trials), "Radiation Therapy" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Marshall University Medical Center" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Marshall University Medical Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Marshall University Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marshall University Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".